Acute myeloid leukemia (AML) is the most common type of adult hematopoietic malignancy. It has a high rate of disease relapse, a consequence of chemoresistance. Recent biological studies suggest that a major component of the relapse phenotype resides in a rare population of leukemic stem cells (LSC), characterized by extensive proliferative and self-renewal potential, and poor response to standard chemotherapeutic agents. We hypothesize that i) common molecular characteristics inherent to LSC-enriched populations reflect the biology of heterogeneous AML with unfavorable prognostic features;ii) these associations can be derived from systematic analysis of gene and microRNA expression profiles, and other biologic characteristics of bulk AML samples. The overarching goal of this project is to define LSC-characterized transcription factor (TF) and microRNA interactions in heterogeneous AMLs. We proposed to integrate both qualified data-driven and curated knowledge about LSC characteristics, and clinical outcomes from bulk AML. Specifically, we will perform meta-analyses on a pathway level to build LSC-specific biology, focusing on AML prognostic TF/microRNA deregulation. These approaches are supported by our two pioneering mathematical methodologies: the Functional Analysis of Individual Microarray Expression (FAIME) and the mechanism-anchored Phenotypes-Genotype Network (PGNet).
F AIM E provides a novel process for transforming extensive available gene expression profiles into individual pathway profiles, resulting in more reproducible pathway signatures (46% overlap among three cohorts, empirical p<0.001). The PGNet method reveals genes regulated by disease-critical regulators and can accurately predict patient outcomes - shifting the paradigm from single gene/microRNA analysis towards """"""""mechanism anchored profiling"""""""". Using PGNet, we have successfully predicted that the epigenetic regulator HDAC9 is associated with survival in acute lymphoblastic leukemia. Innovatively, this project will interrogate microRNAs/genes that regulate LSC-specific biological pathways and AML prognostication, integrating regulator-regulator interactions and regulator-gene interactions.
In Aim 1, we will build LSC-specific gene pathways and identify regulator-gene interactions.
In Aim 2, we will correlate LSC-specific regulators and their target genes corresponding to AML outcomes.
In Aim 3, we will develop novel approaches to computationally model the crucial interactions among the LSC-specific regulators and prognostic gene targets. Both the abundance of available AML patient profiles and the proven ability of our proposed methods suggest that we will achieve our aim to build an LSC-driven prognostic model.

Public Health Relevance

We have long been committed to the development of statistical algorithms and software tools for high-throughput data analyses (e.g. the Bioconductor package OrderedList, the online tools GOModule). These tools allow an effective functional integration of transcriptome information with clinical endpoints. This project will systematically build a pre-clinical model of the leukemic stem cell, a critical subpopulation in acute myeloid leukemia that integrates transcriptome, crucial microRNAs, targeting genes, and other biologic/clinical endpoints. This robust computational structure will facilitate predictions f outcomes and the identification of key oncogenic targets.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Cancer Biomarkers Study Section (CBSS)
Program Officer
Jessup, John M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Chicago
Schools of Medicine
United States
Zip Code
Waldron, Lauren; Steimle, Jeffrey D; Greco, Todd M et al. (2016) The Cardiac TBX5 Interactome Reveals a Chromatin Remodeling Network Essential for Cardiac Septation. Dev Cell 36:262-75
Yang, Xinan Holly; Wang, Bin; Cunningham, John M (2015) Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles. BMC Med Genomics 8 Suppl 2:S6
Wang, Bin; Cunningham, John M; Yang, Xinan Holly (2015) Seq2pathway: an R/Bioconductor package for pathway analysis of next-generation sequencing data. Bioinformatics 31:3043-5
Yang, Xinan Holly; Li, Meiyi; Wang, Bin et al. (2015) Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia. BMC Bioinformatics 16:97
Hoffmann, Andrew D; Yang, Xinan Holly; Burnicka-Turek, Ozanna et al. (2014) Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation. PLoS Genet 10:e1004604
Yang, Xinan; Ai, Xindi; Cunningham, John M (2014) Computational prognostic indicators for breast cancer. Cancer Manag Res 6:301-12
Yang, Xinan; Huang, Yong; Lee, Younghee et al. (2014) In Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment. BMC Med Genomics 7 Suppl 1:S2
Yang, Xinan; Vasudevan, Prabhakaran; Parekh, Vishwas et al. (2013) Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis. PLoS One 8:e56195